Key result
Chronic subdural hematoma in elderly patients is no longer a benign disease, characterized by increasing incidence, a recurrence rate of 10-15%, and poor long-term outcomes with high mortality.
Population
Elderly patients (mainly >65 years old) with chronic subdural hematoma (CSDH)
Design
Review
Authors
Loading...
CSDH in elderly warrants close surveillance for recurrence and mortality; challenges benign classification and leaves open targeted prevention trials.
Chronic subdural hematoma in elderly patients is increasing in incidence and carries significant morbidity, mortality, and recurrence risk, challenging the historical view that it is a benign condition.
Uno et al. (2017) conducted a review in Chronic Subdural Hematoma. Surgical and medical management was evaluated. Chronic subdural hematoma in elderly patients is no longer a benign disease, characterized by increasing incidence, a recurrence rate of 10-15%, and poor long-term outcomes with high mortality.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: